awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26766689-F9DECB42-25B9-43C0-BC42-9C62D3F60E04
Q26766689-F9DECB42-25B9-43C0-BC42-9C62D3F60E04
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26766689-F9DECB42-25B9-43C0-BC42-9C62D3F60E04
Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?
P2860
Q26766689-F9DECB42-25B9-43C0-BC42-9C62D3F60E04
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26766689-F9DECB42-25B9-43C0-BC42-9C62D3F60E04
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2120e792fd0b764c3f210aeceadfadba94b400cd
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.